Completion of the Human Genome Project and pressure for clearer applications have cut the number of US biotech patents.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Trends in genetic patent applications: the commercialization of academic intellectual property
European Journal of Human Genetics Open Access 22 January 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Rogan steps down as USPTO director
Related external links
Rights and permissions
About this article
Cite this article
Lawrence, S. Patent drop reveals pressures on industry. Nat Biotechnol 22, 930–931 (2004). https://doi.org/10.1038/nbt0804-930
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0804-930
This article is cited by
-
The declining impact of the US National Institutes of Health on cancer patenting
Nature Biotechnology (2019)
-
Trends in genetic patent applications: the commercialization of academic intellectual property
European Journal of Human Genetics (2014)
-
An assessment of emerging molecular farming activities based on patent analysis (2002∼2006)
Biotechnology and Bioprocess Engineering (2008)
-
Changing patent strategies: what will they mean for the industry?
Nature Biotechnology (2007)
-
News In Brief
Nature Biotechnology (2005)